Literature DB >> 21220177

Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status.

Seo Hee Choi1, Tae Min Jung, Ji E Lee, Seung-Koo Lee, Young H Sohn, Phil Hyu Lee.   

Abstract

The cholinergic system arising from the substantia innominata (SI) of the basal forebrain has an important role in the cognitive functions of Parkinson's disease (PD). We performed magnetic resonance imaging based volumetric analysis to evaluate the SI volume in patients with PD-intact cognition (PD-IC), PD-mild cognitive impairment (PD-MCI), and PD dementia (PDD). The mean normalized SI volume was significantly decreased in patients with PD-IC (1.54 ± 0.12, p < 0.001), PD-MCI (1.49 ± 0.12, p < 0.001), and PDD (1.39 ± 0.12, p < 0.001) compared with that of control subjects (1.68 ± 0.11). The normalized SI volume did not differ between patients with PD-IC and PD-MCI; however, the normalized SI volume was significantly decreased in patients with PDD compared with that in those with PD-IC (p < 0.001) or PD-MCI (p = 0.016). The normalized SI volume was significantly correlated with general cognitive status (r = 0.51, p < 0.001) as well as with performance in each cognitive subdomain, with a particularly significant independent association with attention (β = 0.33, p = 0.003) and object naming (β = 0.26, p = 0.017). The present study demonstrated that the SI volume in PD differs depending on cognitive status and is significantly correlated with cognitive performance.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21220177     DOI: 10.1016/j.neurobiolaging.2010.11.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  32 in total

1.  An update on brain imaging in parkinsonian dementia.

Authors:  Myria Petrou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Imaging Med       Date:  2012-04

2.  Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.

Authors:  Michel J Grothe; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Stefan J Teipel
Journal:  Cereb Cortex       Date:  2015-04-02       Impact factor: 5.357

Review 3.  The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?

Authors:  María C Rodriguez-Oroz; Belen Gago; Pedro Clavero; Manuel Delgado-Alvarado; David Garcia-Garcia; Haritz Jimenez-Urbieta
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

4.  Early nucleus basalis of Meynert degeneration predicts cognitive decline in Parkinson's disease.

Authors:  James P Gratwicke; Thomas Foltynie
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

5.  Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.

Authors:  Nicolaas I Bohnen; Roger L Albin; Martijn L T M Müller; Myria Petrou; Vikas Kotagal; Robert A Koeppe; Peter J H Scott; Kirk A Frey
Journal:  JAMA Neurol       Date:  2015-02       Impact factor: 18.302

Review 6.  Deep brain stimulation for disorders of memory and cognition.

Authors:  Tejas Sankar; Nir Lipsman; Andres M Lozano
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

7.  New MRI Biomarkers Advance the Characterization of Parkinson Disease.

Authors:  David A Ziegler; Suzanne Corkin
Journal:  Eur Neurol Rev       Date:  2013

Review 8.  Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline.

Authors:  Elizabeth C Ballinger; Mala Ananth; David A Talmage; Lorna W Role
Journal:  Neuron       Date:  2016-09-21       Impact factor: 17.173

9.  Alterations of diffusion tensor MRI parameters in the brains of patients with Parkinson's disease compared with normal brains: possible diagnostic use.

Authors:  Chin-Song Lu; Shu-Hang Ng; Yi-Hsin Weng; Jur-Shan Cheng; Wey-Yil Lin; Yau-Yau Wai; Yao-Liang Chen; Jiun-Jie Wang
Journal:  Eur Radiol       Date:  2016-03-05       Impact factor: 5.315

10.  Substantia nigra volume loss before basal forebrain degeneration in early Parkinson disease.

Authors:  David A Ziegler; Julien S Wonderlick; Paymon Ashourian; Leslie A Hansen; Jeremy C Young; Alex J Murphy; Cecily K Koppuzha; John H Growdon; Suzanne Corkin
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.